Metabolism - Clinical and Experimental
Volume 44, Issue 12 , Pages 1532-1535, December 1995

NG-Methyl-l-arginine and somatostatin decrease glucose and insulin and block endothelin-1 (ET-1)-induced insulin release but not ET-1-induced hypoglycemia☆☆☆

  • Robert S. Zimmerman

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Robert S. Zimmerman, MD, Endocrinology Research, Oshsner Clinic, 1516 Jefferson Highway, New Orleans, LA 70121.
    • ,
  • Michael Maymind

Alton Oshsner Medical Foundation, New Orleans, LA, USA

Received 21 July 1994; accepted 22 May 1995.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Presented in part at the American Federation for Clinical Research, Baltimore, MD, April 30, 1994; Annual Meeting of the Midwest AFCR, Chicago, IL, November 4, 1992; and the American Diabetes Association, Las Vegas, NE, June 15, 1993.

☆☆ Supported by a grant from the Ochsner Medical Foundation.

PII: 0026-0495(95)90070-5

Metabolism - Clinical and Experimental
Volume 44, Issue 12 , Pages 1532-1535, December 1995

Article Tools